Interactive worksheet
Interactive worksheet
Clinical inputs
0/4 filled
Clinical contextWhy this tool matters and how to interpret it
Understand the result,
not just the number.
ESMO Anthracycline Risk Category: Explanation and Clinical Context The ESMO Anthracycline Risk Category is a stratification tool developed to assess the risk of cardiovascular toxicity in patients undergoing anthracycline-based chemotherapy. This tool considers factors such as age, sex, pre-existing cardiovascular disease, and cumulative anthracycline dose to categorize patients into low, moderate, or high-risk groups. Identifying patients at higher risk allows for tailored monitoring and preventive strategies to mitigate potential cardiac complications associated with anthracycline therapy.
Evidence & references1 primary source mapped
- Source 1
Curigliano G, et al. Cardiovascular toxicity induced by chemotherapy, targeted therapies and radiotherapy: ESMO Clinical Practice Guidelines. Ann Oncol. 2012;23(7):ii155-ii166. doi:10.1093/annonc/mds225
Clinical discussionModerated, tool-specific conversation
Loading discussion…